Results 131 to 140 of about 170,658 (215)

Investigations of HLA-F and HLA-G 3'UTR Polymorphisms in Preeclampsia and Fetal Growth Restriction Indicate a Possible Role of HLA-F-HLA-G Haplotypes and Diplotypes. [PDF]

HLA
Møller HI, Christiansen CM, Klok FR, Pedersen NH, Blauenfeldt T, Finne KF, Nielsen HS, Hviid TVF.   +7 more
europepmc   +1 more source

Utilizing primary HLA-G+ extravillous trophoblasts and HLA-G+ EVT-like cell lines to study maternal-fetal interactions. [PDF]

STAR Protoc, 2023
Hamilton I, Ikumi NM, Kshirsagar S, Goodman WA, Tilburgs T.   +4 more
europepmc   +1 more source

Do the expressions of HLA-G and killer cell immunoglobulin-like receptors change in colorectal cancer? [PDF]

Turk J Med Sci
Dinçer E, Kaya Dağistanli F, Peker KD, Sakiz D, Abatay Sel F, Kivanç D, Şentürk Çiftçi H, Kekik Çinar Ç, Karataş Ş, Savran Oğuz F.   +9 more
europepmc   +1 more source

HLA-G Alleles Impact the Perinatal Father-Child HPV Transmission. [PDF]

Curr Issues Mol Biol, 2023
Suominen NT, Roger M, Faucher MC, Syrjänen KJ, Grénman SE, Syrjänen SM, Louvanto K.   +6 more
europepmc   +1 more source

Efficacy, safety and cost‐effectiveness of CAR‐T therapy

British Journal of Clinical Pharmacology, EarlyView.
CAR T‐cells demonstrate high efficacy in blood cancers, including ALL, MM and DLBCL. Innovations target solid tumours despite challenges such as antigen escape. Combination therapies enhance the delivery and infiltration of CAR T cells. Toxicity, cost and resistance remain major barriers to clinical use.
Emina Karahmet Sher, Amina Džidić‐Krivić, Emma Pinjic, Nejra Selak, Kanita Omerbasic, Alexandar Chupin, Andrej Belancic, Almir Fajkic   +7 more
wiley   +1 more source

Cannabidiol (CBD) as a novel inhibitor of HLA-G expression in human choriocarcinoma cell line (JEG-3). [PDF]

Sci Rep
Martínez KI, Palma MB, Sepúlveda FJ, Moavro DE, Carosella ED, García MN, Riccillo FL.   +6 more
europepmc   +1 more source

HLA-G and Recurrent Pregnancy Loss. [PDF]

Int J Mol Sci, 2023
Barbaro G, Inversetti A, Cristodoro M, Ticconi C, Scambia G, Di Simone N.   +5 more
europepmc   +1 more source

Precision medicine in paediatrics: Progress and priorities

British Journal of Clinical Pharmacology, EarlyView.
Precision medicine is revolutionizing personalized healthcare, advancing both diagnostics and therapeutics at an unprecedented pace. Reviewing the paediatric applications of pharmacometrics, pharmacogenomics and advanced therapy medicinal products highlights not only the relevance of these exciting innovations to frontline care but also the significant
Nicola Husain, Claire Booth, Joseph F. Standing, Charlotte I. S. Barker   +3 more
wiley   +1 more source

Nanomaterial‐based immune therapeutic strategies in neurodegenerative diseases

BMEMat, EarlyView.
This review highlights the immunomodulatory potential of nanomaterials (NMs) in treating neurodegenerative diseases (NDs). It focuses on their roles in regulating innate and adaptive immune responses to maintain immune homeostasis. By providing insights into these mechanisms, the review lays the groundwork for innovative NMs therapeutic strategies to ...
Xinru Zhou, Jia Liu, Shulin Lai, Suhan Yin, Bingmin Luo, Longquan Shao, Yiyuan Kang   +6 more
wiley   +1 more source

HLA-G regulation through trogocytosis: intercellular membrane transfer mechanisms and immune dysregulation in Systemic Lupus Erythematosus. [PDF]

Front Cell Dev Biol
Karmakar A, Kumar U, Kamath R, Singh H, Prabhu MM, Karmakar S.   +5 more
europepmc   +1 more source